1. Catalogs
  2. Bruker Daltonics Inc.
  3. MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry
video corpo

MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry

MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry

MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry

Product catalog summary
Abstract
This study utilizes mass spectrometry to analyze necroptotic cell death mediated by MLKL. Native mass spectrometry was used to observe MLKL oligomer stoichiometry, while cross-linking LC-MS examined oligomer orientation on membranes. Small-Angle X-Ray Scattering, combined with mass spectrometry data, facilitated modeling of the MLKL complex.

Introduction
Necroptosis is a form of programmed cell death distinct from apoptosis, executed by MLKL. Upon activation, MLKL oligomerizes and permeabilizes membranes. The study hypothesizes that the PsK domain acts as a molecular switch, affecting MLKL's conformation and function.

Experimental Materials and Methods
Native Mass Spectrometry: Conducted using Bruker maXis II ETD UHR-QTOF, analyzing recombinant MLKL and its mutant. Crosslinking Mass Spectrometry: Employed chemical cross-linkers and analyzed using Impact II UHR-QTOF. Data Analysis: Utilized MaxQuant and StavroX software for peptide identification and cross-link mapping.

Results
Oligomer Stoichiometry: Native mass spectrometry revealed that MLKL forms a tetramer, which is disrupted by the E351K mutation or ATP. Membrane Permeabilization: Liposome dye-release assays indicated that wild-type MLKL effectively permeabilizes membranes, whereas the E351K mutation reduces this activity. Modeling MLKL Tetramer: Small Angle X-ray Scattering and XL-MS data were used to model MLKL's tetrameric structure, suggesting a daisy-chain arrangement.

Conclusions
Mass spectrometry techniques characterized MLKL's transition from monomer to tetramer. The study demonstrated the effectiveness of Bruker UHR-QTOF instruments in analyzing protein complexes, providing insights into MLKL's structural changes essential for necroptosis.
See more

Catalog excerpts

MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry-1

MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry This study utilized multiple mass spectrometry techniques to characterise necroptotic cell death which is mediated by the pseudokinase, mixed lineage kinase domain-like (MLKL). The mass spec data enabled more precise models using Small-Angle X-Ray Scattering analysis. Abstract Activated MLKL oligomer stoichiometry was directly observed using native mass spectrometry on the maXis II ETD UHR-QTOF. Additionally, chemical cross-linking was then used investigate the orientation of the oligomeric MLKL complex on the membrane with LC-MS (XL-MS) analysis on the Impact II UHR-QTOF [1]. Finally, Small Angle X-ray Scattering analysis coupled to inline sizeexclusion chromatography (SEC) using constraints from the native mass spectrometry and XL-MS data enabled modeling of this complex. Introduction Necroptosis is a programmed cell death mechanism in which the plasma membrane is compromised, allowing escape of the cell’s contents and instigation of an inflammatory response. In contrast to apoptosis, necroptosis is a caspase-independent cell death Authors: Jarrod J Sandow 1,2, Emma J Petrie 1,2, Andrew I Webb 1,2, James M Murphy 1,2; 1   he Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; 2 Department of Medical Biology, The University of Melbourne, T Parkville, Victoria

 Open the catalog to page 1
MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry-2

MLKLWT +ATP Relative intensity [%] Relative intensity [%] Relative intensity [%] Figure 1: Tetrameric MLKL is destabilized by ATP or PsK domain mutation to a monomeric intermediate. Mass spectra of wild-type and E351KMLKL with or without the addition of ATP measured by native mass spectrometry on the maXis II ETD UHR-QTOF pathway, which is executed by the terminal protein, mixed lineage kinase domain-like (MLKL). MLKL activation promotes oligomerization, translocation to the inner plasma membrane and ensuing necroptotic cell death by membrane permeabilization, although the precise molecular details...

 Open the catalog to page 2
MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry-3

Bruker UHR-QTOF platforms can be used to gain significant insights into how reorientation of sidechains in the MLKL PsK domain promotes the structural change and selfassociation of MLKL that are essential for necroptosis. Experimental materials and methods Native Mass spectrometry Native-spray of larger proteins at neutral pH conditions results in molecular ions with relatively low numbers of charges. In addition, the absence of organic solvent in native MS requires enhanced desolvation conditions. A Bruker maXis II ETD UHR-QTOF instrument capable of 80,000 resolving power was used. Recombinant...

 Open the catalog to page 3
MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry-4

(https://www.wehi.edu.au/people/ andrew-webb/129 8/apl - mgf- con verter). Cross-linked peptides were identified from the MGF files using StavroX software (version 3.6.0.1). Lysines, protein N-termini, serines and threonines were set as reaction sites of the cross-linker NHS-esters. Trypsin was set as the enzyme allowing for 3 missed cleavages at lysines and 2 at arginines. Precursor precision was set at 10 ppm with fragment ion precision set at 20 ppm. Results Determining oligomer stoichiometry using native mass spectrometry In cells, cytosolic MLKL is monomeric prior to activation. This led...

 Open the catalog to page 4
MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry-5

Theor. Mass (M+H): 1742.017 Observ. Mass (M+H): 1742.017 Deviation: -0.04 ppm m/z: 436.2597 +4 Table 1: Table presenting inter-subunit MLKL tetramer cross-links from DSS and BS3 using the Impact II UHR-QTOF. Minimum distance relates to the minimum cross-link span in the MLKL tetramer model subtracted, with Guinier analysis indicating the data were monodisperse with a maximum particle dimension of 170 A. We generated a tetrameric model of MLKL to fit these scattering data by rigid-body modelling of the reported model for MLKL using maximum 35 A distance restraints between Lys157-Lys157, Lys173-Lys173...

 Open the catalog to page 5
MLKL Activation and Oligomerisation analysis using cross-linking LC-MS and Native Mass Spectrometry-6

Learn More You are looking for further Information? Check out the link or scan the QR code for more details. [1] Petrie EJ, Sandow JJ (2018) Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis. Nat. Comm. Jun 21;9(1):2422 [2] Marty MT. (2015 ) Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal Chem. Apr 21;87(8):4370-6). [3] Forbes S.A. et al. (2017). COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 45, D777-D783. [4] Murphy J.M. et al. (2014)....

 Open the catalog to page 6

All Bruker Daltonics Inc. catalogs and technical brochures

  1. neofleX™

    12  Pages

  2. timsOmniTM

    20  Pages

Archived catalogs

  1. Toxtyper

    6  Pages

  2. impact HD

    12  Pages

  3. solarix XR

    12  Pages

  4. SIGIS II

    2  Pages

  5. VeroTect

    4  Pages

  6. µRAID

    4  Pages

  7. MM2

    6  Pages

  8. RAID M100

    6  Pages

  9. RAID S2

    6  Pages

  10. RAID XP

    4  Pages

  11. RAID AFM

    4  Pages

  12. pTD

    2  Pages

  13. DE-tector

    6  Pages

  14. ImagePrep

    4  Pages

  15. micrOTOF II

    8  Pages

  16. impact II

    12  Pages

  17. EVOQ

    6  Pages

  18. maxis II

    12  Pages

  19. ProteinScape

    8  Pages

  20. MALDI Imaging

    16  Pages

  21. MBT Pharma

    8  Pages

  22. MBT BTS US

    2  Pages

  23. MBT SMART IVD

    4  Pages

  24. MBT Pilot RUO

    4  Pages

  25. timsTOF Pro

    6  Pages

  26. timsTOF™

    8  Pages

  27. TASQ Software

    4  Pages

  28. Metabolomics

    8  Pages

  29. spotOn™

    4  Pages

  30. Toxtyper

    8  Pages

  31. CMC-assist

    2  Pages

  32. EVOQ - 2014

    6  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.